Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

38 publications

Funding

6 grantsView NIH portfolio on RePORTER ↗

Active

3 grants
  • Co-I
    PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers
    National Cancer Institute · 2024–2029
    75N91024D00006
  • Co-I
    PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers - Master Agreement
    National Cancer Institute · 2024–2029
    75N91024D00006
  • Co-I
    CAP-IT Center for LNP RNA Immunoprevention
    National Cancer Institute · 2022–2027
    U54CA272688-01
Completed grants (3)
  • KP
    Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
    National Cancer Institute · 2017–2023
    P50CA211024-05
  • MPI
    Anti-Y. pestis Vaccination and Passive Protection
    NIAID · 2003–2007 · via NIH RePORTER
    R01AI055844-05
  • PI
    Genetic Passive Immunotherapy for Shiga toxin
    NIAID · 2004–2006 · via NIH RePORTER
    R21AI060968-02

News mentions

1 mentionView all WCM news ↗